What can the history of asserted patents tell us?

What pointers can we get to improve? I have analyzed 9,600 asserted patents from the last five years, and I am sharing a number of key findings, starting with insights drawn from claim analysis.

• Across most industries, asserted patents have shorter independent claims. Only ~10% exceed 300 words. However in pharma, biotech, healthcare, and education, the pattern flips.

• Asserted patents combine shorter claims with much richer disclosure. That combination shows up far more often than I expected.

Sign up for the full report and discover all the insights drawn from claims analysis.

This is the first blog in a short series on how portfolios can be shaped from the patent up, using litigation outcomes rather than intuition. Look out for blogs on:

• Industry cuts
• Plaintiff behavior
• Distributions
• Drafting implications

Sign up for the full report.